Author Question: Which of the following criteria should be met before considering use of a heat-moisture ex-changer ... (Read 37 times)

melly21297

  • Hero Member
  • *****
  • Posts: 565
Which of the following criteria should be met before considering use of a heat-moisture ex-changer (HME) for a patient being placed on ventilatory support?
 
  1. There should be no problem with retained secretions.
  2. The patient should not have fever (normothermic).
  3. The patient should be adequately hydrated.
  4. The support should be short term (24 to 48 hr).
  a. 1, 2, and 3 only
  b. 2 and 4 only
  c. 1, 2, 3, and 4
  d. 3 and 4 only

Question 2

A patient suffering from postoperative complications has been receiving mechanical ventilation for 6 days with a volume ventilator.
 
  A heat-moisture exchanger (HME) is providing control over humidification and airway tempera-ture. Over the past 24 hr, the patient's secretions have decreased in quantity but are thicker and more purulent. Which of the following actions would you suggest at this time?
  a. Replace the HME.
  b. Switch over to a heated wick humidifier.
  c. Administer acetylcysteine every 2 hr via the nebulizer.
  d. Increase the frequency of suctioning.



shailee

  • Sr. Member
  • ****
  • Posts: 392
Answer to Question 1

ANS: C
Use of HMEs should be avoided in the care of patients with secretion problems and those with low body temperature (<32 C), high spontaneous minute ventilation (>10 L/min), or air leaks in which exhaled tidal volume is less than 70 of delivered tidal volume.

Answer to Question 2

ANS: B
We prefer an optimal humidity approach and use of a heated humidifier to deliver gas in the range of 35 to 37 C at the airway.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

The effects of organophosphate poisoning are referred to by using the abbreviations “SLUD” or “SLUDGE,” It stands for: salivation, lacrimation, urination, defecation, GI upset, and emesis.

Did you know?

The strongest synthetic topical retinoid drug available, tazarotene, is used to treat sun-damaged skin, acne, and psoriasis.

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

Did you know?

Though newer “smart” infusion pumps are increasingly becoming more sophisticated, they cannot prevent all programming and administration errors. Health care professionals that use smart infusion pumps must still practice the rights of medication administration and have other professionals double-check all high-risk infusions.

For a complete list of videos, visit our video library